Everolimus With Reduced-Dose Cyclosporine in De Novo Renal Transplant Recipients: Philippine Experience

Transplantation Proceedings

Volumn 40, Issue 7, 2008, Pages 2211-2213

  Li, J T ^a   Danguilan, R A ^a   Cabanayan Casasola, C B ^a   Talusan Tomacruz, Y ^a   Ona, E T ^a  

^a National Kidney and Transplant Institute Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN A; EVEROLIMUS; ISONIAZID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NYSTATIN; PREDNISONE; STEROID; TACROLIMUS; VALACICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CHEMISTRY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG DOSE REDUCTION; FILIPINO; GRAFT REJECTION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; CREATININE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHILIPPINES; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 51249098540     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.06.041     Document Type: Article

References (4)

1. Vitko S., Margreiter R., Weimar W., et al. Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients. Transplantation 78 (2004) 1532
2. Lorber M.I., Mulgaonkar S., Butt K.M.H., et al. Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3 year randomized, multicenter, phase III study. Transplantation 80 (2005) 244
3. Tedesco H., Ambuhl P., Lorber M.I., et al. Improved renal functioning following cyclosporine dose reduction in maintenance renal transplant recipients taking everolimus (certican). Presented at the American Transplant Congress. Washington, DC (April 2002)
4. Vitko S., Tedesco H., Eris J., et al. Everolimus with optimised cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomised studies. Am J Transplant 4 (2004) 626